177 related articles for article (PubMed ID: 37302927)
1. Cardiovascular risk in vasculitis.
Misra DP; Sharma A; Karpouzas GA; Kitas GD
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101831. PubMed ID: 37302927
[TBL] [Abstract][Full Text] [Related]
2. Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021.
Henes J; Richter JG; Thiele K; Kiltz U; Callhoff J; Albrecht K
Rheumatol Int; 2024 Mar; 44(3):497-507. PubMed ID: 38180499
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells and systemic vasculitis.
Mirouse A; Cacoub P; Saadoun D
Curr Opin Rheumatol; 2023 Jan; 35(1):25-30. PubMed ID: 36508306
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of systemic vasculitis.
Ozguler Y; Esatoglu SN; Hatemi G
Curr Opin Rheumatol; 2024 Jan; 36(1):21-26. PubMed ID: 37800639
[TBL] [Abstract][Full Text] [Related]
5. Updates in cutaneous manifestations of systemic vasculitis.
Elbendary A; Abdel-Halim MRE; Ragab G
Curr Opin Rheumatol; 2022 Jan; 34(1):25-32. PubMed ID: 34690279
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary manifestations of large, medium, and variable vessel vasculitis.
Adams TN; Zhang D; Batra K; Fitzgerald JE
Respir Med; 2018 Dec; 145():182-191. PubMed ID: 30509707
[TBL] [Abstract][Full Text] [Related]
7. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis in vasculitis.
Gaffo AL
Best Pract Res Clin Rheumatol; 2013 Feb; 27(1):57-67. PubMed ID: 23507057
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis research: Current trends and future perspectives.
Misra DP; Naidu GSRSNK; Agarwal V; Sharma A
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():10-20. PubMed ID: 30168260
[TBL] [Abstract][Full Text] [Related]
10. Biotherapies in large vessel vasculitis.
Ferfar Y; Mirault T; Desbois AC; Comarmond C; Messas E; Savey L; Domont F; Cacoub P; Saadoun D
Autoimmun Rev; 2016 Jun; 15(6):544-51. PubMed ID: 26883459
[TBL] [Abstract][Full Text] [Related]
11. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in vasculitis.
Springer J; Villa-Forte A
Curr Opin Rheumatol; 2013 Jan; 25(1):19-25. PubMed ID: 23143223
[TBL] [Abstract][Full Text] [Related]
13. Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.
Delaval L; Samson M; Schein F; Agard C; Tréfond L; Deroux A; Dupuy H; Garrouste C; Godmer P; Landron C; Maurier F; le Guenno G; Rieu V; Desblache J; Durel CA; Jousselin-Mahr L; Kassem H; Pugnet G; Queyrel V; Swiader L; Blockmans D; Sacré K; Lazaro E; Mouthon L; Aumaître O; Cathébras P; Guillevin L; Terrier B;
Arthritis Rheumatol; 2021 Feb; 73(2):286-294. PubMed ID: 32951354
[TBL] [Abstract][Full Text] [Related]
14. Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu's arteritis, ANCA-associated vasculitis and giant cell arteritis.
Gutierrez-Rodrigues F; Wells KV; Jones AI; Hironaka D; Rankin C; Gadina M; Sikora KA; Alemu L; Calado RT; Quinn KA; Patel B; Young NS; Grayson PC
Ann Rheum Dis; 2024 Mar; 83(4):508-517. PubMed ID: 38049983
[TBL] [Abstract][Full Text] [Related]
15. Risk of acute myocardial infarction, stroke, and venous thromboembolism among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in South Korea: A nationwide population-based study.
Ahn JK; Hwang J; Choi CB; Seo GH
Joint Bone Spine; 2023 Mar; 90(2):105498. PubMed ID: 36423779
[TBL] [Abstract][Full Text] [Related]
16. Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives.
Argyropoulou OD; Protogerou AD; Sfikakis PP
Curr Opin Rheumatol; 2018 Jan; 30(1):36-43. PubMed ID: 29040156
[TBL] [Abstract][Full Text] [Related]
17. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides.
Sener S; Arslanoglu Aydin E; Batu ED
Clin Rheumatol; 2023 Mar; 42(3):673-686. PubMed ID: 36369404
[TBL] [Abstract][Full Text] [Related]
18. Environmental Triggers for Vasculitis.
Katz G; Wallace ZS
Rheum Dis Clin North Am; 2022 Nov; 48(4):875-890. PubMed ID: 36333001
[TBL] [Abstract][Full Text] [Related]
19. Early development of new cardiovascular risk factors in the systemic vasculitides.
Monti S; Robson J; Klersy C; Kraven A; Montecucco C; Watts R; Merkel PA; Luqmani R
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):126-134. PubMed ID: 31498071
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis.
Michailidou D; Duvvuri B; Kuley R; Cuthbertson D; Grayson PC; Khalidi NA; Koening CL; Langford CA; McAlear CA; Moreland LW; Pagnoux C; Seo P; Specks U; Sreih AG; Warrington KJ; Mustelin T; Monach PA; Merkel PA; Lood C
Arthritis Res Ther; 2022 Jun; 24(1):160. PubMed ID: 35768848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
